Request PDF on ResearchGate | On Feb 1, , Hugo Donato and others published Tratamiento con eritropoyetina humana recombinante. Se demostró que el tratamiento con eritropoyetina humana recombinante (EPO rHu) en pacientes en diálisis es altamente efectivo en cuanto a la corrección de. Eritropoyetina humana recombinante para la anemia de la insuficiencia renal crónica en pacientes en prediálisis. This is not the most recent version of this.
|Country:||Bosnia & Herzegovina|
|Published (Last):||15 May 2017|
|PDF File Size:||11.55 Mb|
|ePub File Size:||16.86 Mb|
|Price:||Free* [*Free Regsitration Required]|
Available for Android and iOS devices. Nephrol Dial Transplant ;19 Suppl 2: Main characteristics of the patients ACEI: Br J Clin Pharmacol ; Ertiropoyetina an impact of age on Epo elimination in our patients cannot be fully excluded, neither age nor other covariates that differed between the groups was found affect Epo elimination in the ANCOVA model.
Eritropoyetina Humana Recombinante –
A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection. We recently showed that BEN hemodialysis patients required a higher dose of recombinant human erythropoietin for maintaining the target hemoglobin level than patients with other kidney diseases.
However, several authors reported no significant differences between anemia in BEN and humanq kidney diseases. The values of C max and t max are comparable to those found by other authors, taking into account the above mentioned differences in methodology.
Kidney Int Suppl ; Comparison of the pharmacokinetics of beta-erythropoietin recombinanhe subcutaneously to hemodialysis patients with BEN or other kidney diseases non-BEN. Renal function, protein excretion and pathology of Balkan endemic nephropathy. Clin J Am Soc Nephrol ;3: Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
To view content sources and attributions, please refer to our editorial policy. No significant differences between groups were found in maximal Epo concentration, recombinant to maximum Epo concentration, area under the curve from time of dosing extrapolated to infinity, clearance, mean residence time of Epo between groups both before and after adjustment.
Pavlovic-Kentera V, Djukanovic Lj. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.
Available for Android and iOS devices. Balkan endemic nephropathy BEN hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases. Methods Study design and patients The prospective clinical study was performed according to good clinical practice and in accordance with the Recombinanye of Helsinki in three clinical centers.
C reactive protein; Epo: Population pharmacokinetics of erythropoietin in critically ill subjects.
Eritropoyetina Humana Recombinante Delta –
Statistical analysis The results were expressed as mean values with standard deviations. Predialysis serum creatinine and PTH concentrations were significantly lower, and serum calcium concentration was significantly higher in the BEN than in the non-BEN group. The enigma of the metabolic fate of recombinantw erythropoietin Epo in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. Eritropoyetina Humana Recombinante Eritropoyetina Humana Recombinante may be available in the countries listed below.
Eritropoyetina Humana Recombinante Delta
Results of laboratory analyses in the examined individuals are given in Table 2. Renal Injury from Drugs and Chemicals, third edition.
Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis.
N Engl J Med ; The results were expressed as mean values with standard deviations. NDT Plus ;2 Suppl 1: J Pharm Sci ;